RSS-Feed abonnieren
DOI: 10.1055/s-0043-1774181
Asphodelus bento-rainhae and Asphodelus macrocarpus root extracts pre- clinical safety assessments
Herbal medicines generally have minimal safety concerns compared to synthetic medicines; however, they are not free from toxicity or side effects. Due to the significant increase in global consumption, the safety of herbal medicines has been highlighted. Asphodelus bento-rainhae subsp. bento-rainhae and Asphodelus macrocarpus subsp. macrocarpus root tubers have been traditionally used in Portugal to treat inflammatory and infectious skin diseases. Given the lack of scientific evidence on the safety and efficacy of both Asphodelus medicinal plants, the present study aims to evaluate the toxicity of their hydroethanolic (70% and 96%) root extracts. Cytotoxicity was assessed by MTT assay using HepG2 and HaCaT cells and genotoxicity by bacterial reverse mutation assay (Ames test) with and without metabolic activation according to OECD guidelines. The obtained results showed no cytotoxic (up to 125 μg/mL) or genotoxic/mutagenic potential (up to 5000 μg/plate, with/without metabolic activation) for the two extracts of both species. Although further studies are needed to complete the safety profile of these two medicinal plants, the obtained negative results provide relevant contributions to their toxicological profiles and important contributions to their future use as therapeutic resources.
Publikationsverlauf
Artikel online veröffentlicht:
16. November 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany